Showing 1 – 20 of 2788
Relevance | Newest | Oldest |
  • Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

    Abstract Full Text
    free access is active quiz
    JAMA. 2017; 317(2):165-182. doi: 10.1001/jama.2016.19043

    This population epidemiology study uses pooled global health evaluation surveys data to estimate trends in the association between elevated stystolic blood pressure and death and disability between 1990 and 2015.

  • JAMA January 10, 2017

    Figure 4: Projected Global Disability-Adjusted Life-Years by Systolic Blood Pressure Level and Country or Region, 2015

    Reported data include both sexes combined and individuals aged 25 years and older. Data are reported for the 3 most populous countries (United States, China, and India) to highlight burden at the highest population levels and utility of country-specific results. Data for other countries and regions are presented on a regional scale using super regions from the Global Burden of Diseases, Injuries, and Risk Factors study 2015 (the regions that contain the United States, China, and India were excluded to prevent double representation of the following results: high income, South Asia, Southeast Asia, East Asia, and Oceania) and have presented the remainder of countries from those super regions as an additional group. The boxes show the median and extend from the 25th to the 75th percentiles. The upper whiskers extend from the third quartile to the highest value within 1.5 × the IQR of the third quartile; the lower whiskers extend from the first quartile to the lowest value within 1.5 × the IQR of the first quartile. Data outside the whisker range are plotted as open circles.aCategory includes 45 countries.
  • Total Expenditures per Patient in Hospital-Owned and Physician-Owned Physician Organizations in California

    Abstract Full Text
    free access
    JAMA. 2014; 312(16):1663-1669. doi: 10.1001/jama.2014.14072

    Robinson and Miller determine whether total expenditures per patient were higher in medical groups owned by local hospitals or multihospital systems compared with groups owned by participating physicians in California between 2009 and 2012.

  • JAMA January 8, 2014

    Figure 1: Estimated Age-Standardized Prevalence of Daily Smoking and Annualized Rate of Change, 1980-2012

    See the Supplement for full list of developing and developed countries, as defined by the Global Burden of Disease Study. For 6 countries without data on tobacco smoking prevalence (Afghanistan, Angola, Central African Republic, Guineau-Bissau, Somalia, Turkmenistan), estimates were derived based on tobacco consumption and trends in prevalence in neighboring countries. The Supplement has more details on these methods. A, Global (187 countries) age-standardized prevalence estimates by sex and separately for developed countries (50 countries) and developing countries (137 countries) from 1980 to 2012. B, Annualized rate of change in age-standardized prevalence by sex from 1980 to 2012. Annualized rates of change are plotted at the beginning of the time interval they correspond to (eg, the rate of change shown for 2011 is the rate of change between 2011 and 2012). Shaded areas designate 95% uncertainty intervals. Interactive data display.
  • JAMA January 8, 2014

    Figure 2: Estimated Prevalence of Daily Smoking and Annualized Rate of Change by Age, 2012

    See the Supplement for full list of developing and developed countries, as defined by the Global Burden of Disease Study. For 6 countries without data on tobacco smoking prevalence (Afghanistan, Angola, Central African Republic, Guinea-Bissau, Somalia, Turkmenistan), estimates were derived based on tobacco consumption and trends in prevalence in neighboring countries. The Supplement has more details on these methods. A, Global (187 countries) prevalence estimates by age group and separately for developed countries (50 countries) and developing countries (137 countries) for 2012. B, Annualized rates of change from 1980 to 2012 by age group and sex. Shaded areas designate 95% uncertainty intervals. Interactive data display.
  • Industry-Sponsored Clinical Trials in Emerging Markets: Time to Review the Terms of Engagement

    Abstract Full Text
    JAMA. 2013; 310(9):907-908. doi: 10.1001/jama.2013.276913
  • The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors

    Abstract Full Text
    free access has multimedia
    JAMA. 2013; 310(6):591-606. doi: 10.1001/jama.2013.13805

    The US Burden of Disease Collaborators used a systematic analysis of descriptive epidemiology of diseases and injuries, their sequelae, and risk factors or clusters of risk factors from 1990 to 2010 to describe the health status of the United States. In an editorial, Fineberg discusses the health of the US population.

  • The State of Health in the United States

    Abstract Full Text
    JAMA. 2013; 310(6):585-586. doi: 10.1001/jama.2013.13809
  • China’s Shifting Burden of Disease

    Abstract Full Text
    JAMA. 2013; 310(3):250-250. doi: 10.1001/jama.2013.17109
  • Dual Disease Burden

    Abstract Full Text
    JAMA. 1999; 281(22):2078-2078. doi: 10.1001/jama.281.22.2078-JWM90004-3-1
  • Importance of Functional Measures in Predicting Mortality Among Older Hospitalized Patients

    Abstract Full Text
    free access
    JAMA. 1998; 279(15):1187-1193. doi: 10.1001/jama.279.15.1187
  • Interpreting Cost Analyses of Clinical Interventions

    Abstract Full Text
    JAMA. 1998; 279(1):54-57. doi: 10.1001/jama.279.1.54
  • Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia: A Randomized Controlled Trial

    Abstract Full Text
    free access
    JAMA. 2003; 290(20):2693-2702. doi: 10.1001/jama.290.20.2693
  • Insuring Latinos Against the Costs of Illness

    Abstract Full Text
    JAMA. 1993; 269(7):889-894. doi: 10.1001/jama.1993.03500070069031
  • Short-term Quality-of-Life Outcomes Following Laparoscopic-Assisted Colectomy vs Open Colectomy for Colon Cancer: A Randomized Trial

    Abstract Full Text
    free access
    JAMA. 2002; 287(3):321-328. doi: 10.1001/jama.287.3.321
  • Health-Related Quality of Life as a Predictor of Mortality Following Coronary Artery Bypass Graft Surgery

    Abstract Full Text
    free access
    JAMA. 1999; 281(14):1298-1303. doi: 10.1001/jama.281.14.1298
  • Hospital Mortality, Length of Stay, and Preventable Complications Among Critically Ill Patients Before and After Tele-ICU Reengineering of Critical Care Processes

    Abstract Full Text
    free access
    JAMA. 2011; 305(21):2175-2183. doi: 10.1001/jama.2011.697
  • Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries

    Abstract Full Text
    free access is active quiz has multimedia
    JAMA. 2016; 315(3):272-283. doi: 10.1001/jama.2015.18603

    This cohort study uses international claims and registry data to describe site of death, health care utilization, and hospital expenditures in the 180-day and 30-day periods before death among elderly patients with cancer in 7 developed countries.

  • Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients: A Randomized Trial

    Abstract Full Text
    free access
    JAMA. 2009; 301(5):489-499. doi: 10.1001/jama.2009.56
  • Effect of an Enhanced Medical Home on Serious Illness and Cost of Care Among High-Risk Children With Chronic Illness: A Randomized Clinical Trial

    Abstract Full Text
    free access has multimedia
    JAMA. 2014; 312(24):2640-2648. doi: 10.1001/jama.2014.16419

    This randomized clinical trial reports that among high-risk children with chronic illness, an enhanced medical home that provided comprehensive care to promote prompt effective care reduced serious illnesses and costs compared with the provision of usual care.